Biostem Technologies Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BSEM Over the counter 2834 https://www.biostemtechnologies.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biostem Technologies Inc

BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House - Sep 19th, 2018 7:00 am
Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group for Pre-Investigational New Drug Application Strategy - Sep 17th, 2018 8:43 am
Nesvik Pharmaceuticals, Inc., Receives Updated U.S. FDA Establishment Registration in Light of New Product Development - Aug 28th, 2018 8:10 am
BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements - Aug 17th, 2018 7:30 am
BioStem Technologies, Inc. Engages Maxim Group LLC For Strategic Advisory Services - Aug 15th, 2018 7:00 am
BioStem Technologies, Inc. (BSEM) Launches New Subsidiary to Engage in the Processing and Supply of Regenerative Tissue Products - Aug 9th, 2018 7:00 am
BioStem Technologies Inc. Launches Expanded Shareholder Communications Initiative - Aug 8th, 2018 7:00 am
BioStem Technologies (BSEM) Subsidiary Nesvik Pharmaceuticals Announces the Completion of An Asset Purchase of Multiple New Drug Compounds and Launches Joint Development Venture with CCM Pharma Solutions - Jul 19th, 2018 7:00 am